Beyfortus is an injection given directly to your baby that provides fast-acting antibody protection (immunization) against serious RSV lung infection. Beyfortus is recommended for newborns and babies born during or entering their first RSV season.

Discover Beyfortus® (nirsevimab-alip) injection - fast acting RSV protection for your baby. Learn how it works and how to get it. See Patient Information Sheet.

Beyfortus® (nirsevimab-alip) injection may be available at no cost through the Vaccines for Children program or your private health insurance. Find out how.

Explore tips and tools to help discuss RSV and Beyfortus® (nirsevimab-alip) injection with your doctor, facts to share with friends and family, and more!

Sign up today to get important updates about RSV and Beyfortus. You'll also get reminders about how and when to protect your baby, all customized just for you. All fields are required unless marked optional.

Sanofi is committed to ensuring an ample supply of Beyfortus to immunize every eligible baby in the US this season.

Sanofi is committed to ensuring an ample supply of Beyfortus to immunize every eligible baby in the US this season.

了解Beyfortus® (nirsevimab-alip) 注射劑如何為您的寶寶提供快速有效的RSV保護。 了解保護方式以及如何取得。 詳情請參閱患者資訊。

Beyfortus是一種直接注射到您寶寶身體的針劑，可提供快速的抗體保護（免疫）以預防嚴重的RSV肺部感染。Beyfortus適用於正值或進入第一個RSV好發季節時出生的新生兒或未滿1歲的嬰兒。

Beyfortus es una inyección que se administra directamente a tu bebé y que brinda protección de anticuerpos de acción rápida (inmunización) contra una infección pulmonar grave por el VRS. Beyfortus se recomienda para recién nacidos y bebés nacidos durante o a inicios de su primera temporada del VRS.